Drupal.behaviors.print = function(context) {window.print();window.close();}>
Cancer Dx Firm Metamark Genetics Raises $22M
July 13, 2010
Cancer Dx Firm Metamark Genetics Raises $22M
The company plans to raise a total of about $42 million for the round, it said in an SEC filing.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Metamark Genetics Completes $13M Series B Round as President and CEO Resigns
November 5, 2012 / GenomeWeb Daily News
Stat-Diagnostica Raises $22.1M in Private Financing Round
May 6, 2013 / GenomeWeb Daily News
MDx Firm Curetis Raises $16.3M in Series B Round
April 22, 2013 / GenomeWeb Daily News
T2 Biosystems Raises $40M
March 28, 2013 / GenomeWeb Daily News
Asuragen Raises $7.5M
March 22, 2013 / GenomeWeb Daily News